# Molina Healthcare, Inc.: financial statements, quarterly

MOH · NYSE · CIK 1179929 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/moh.md) · [Financials](/companies/moh/financials.md) · [Filings](/companies/moh/filings.md) · [Insiders](/companies/moh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/moh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.0 d](/filings/0001179929-26-000005.md) | [9.9](/filings/0001179929-25-000070.md) | [9.9](/filings/0001179929-25-000119.md) | [10.3](/filings/0001179929-25-000128.md) | [10.5 d](/filings/0001179929-26-000005.md) | [11.1](/filings/0001179929-26-000023.md) | [11.4](/filings/0001179929-26-000039.md) | [11.5](/filings/0001179929-26-000045.md) | [11.4 d](/filings/0001179929-26-000005.md) | [10.8](/filings/0001179929-26-000023.md) | [10.9](/filings/0001179929-26-000039.md) | [11.1](/filings/0001179929-26-000045.md) |
| Cost of revenue | $bn | [7.5 d](/filings/0001179929-26-000005.md) | [8.4](/filings/0001179929-25-000070.md) | [8.4](/filings/0001179929-25-000119.md) | [8.6](/filings/0001179929-25-000128.md) | [9.0 d](/filings/0001179929-26-000005.md) | [9.5](/filings/0001179929-26-000023.md) | [9.8](/filings/0001179929-26-000039.md) | [10.0](/filings/0001179929-26-000045.md) | [10.1 d](/filings/0001179929-26-000005.md) | [9.3](/filings/0001179929-26-000023.md) | [9.4](/filings/0001179929-26-000039.md) | [9.7](/filings/0001179929-26-000045.md) |
| Gross profit | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [0.3 d](/filings/0001179929-26-000005.md) | [0.4](/filings/0001179929-25-000070.md) | [0.4](/filings/0001179929-25-000119.md) | [0.5](/filings/0001179929-25-000128.md) | [0.4 d](/filings/0001179929-26-000005.md) | [0.4](/filings/0001179929-26-000023.md) | [0.4](/filings/0001179929-26-000039.md) | [0.1](/filings/0001179929-26-000045.md) | [(0.2) d](/filings/0001179929-26-000005.md) | [0.1](/filings/0001179929-26-000023.md) | [0.1](/filings/0001179929-26-000039.md) | [0.1](/filings/0001179929-26-000045.md) |
| Interest expense | $bn | [0.0 d](/filings/0001179929-24-000033.md) | [0.0](/filings/0001179929-24-000089.md) | [0.0](/filings/0001179929-25-000119.md) | [0.0](/filings/0001179929-25-000128.md) | [0.0 d](/filings/0001179929-26-000005.md) | [0.0](/filings/0001179929-26-000023.md) | [0.0](/filings/0001179929-26-000039.md) | [0.0](/filings/0001179929-26-000045.md) | [0.1 d](/filings/0001179929-26-000005.md) | [0.1](/filings/0001179929-26-000023.md) | [0.1](/filings/0001179929-26-000039.md) | [0.1](/filings/0001179929-26-000045.md) |
| Income tax | $bn | [0.1 d](/filings/0001179929-26-000005.md) | [0.1](/filings/0001179929-25-000070.md) | [0.1](/filings/0001179929-25-000119.md) | [0.1](/filings/0001179929-25-000128.md) | [0.1 d](/filings/0001179929-26-000005.md) | [0.1](/filings/0001179929-26-000023.md) | [0.1](/filings/0001179929-26-000039.md) | [0.0](/filings/0001179929-26-000045.md) | [(0.1) d](/filings/0001179929-26-000005.md) | [0.0](/filings/0001179929-26-000023.md) | [0.0](/filings/0001179929-26-000039.md) | [0.0](/filings/0001179929-26-000045.md) |
| Net income | $bn | [0.2 d](/filings/0001179929-26-000005.md) | [0.3](/filings/0001179929-25-000128.md) | [0.3](/filings/0001179929-25-000128.md) | [0.3](/filings/0001179929-25-000128.md) | [0.3 d](/filings/0001179929-26-000005.md) | [0.3](/filings/0001179929-26-000045.md) | [0.3](/filings/0001179929-26-000045.md) | [0.1](/filings/0001179929-26-000045.md) | [(0.2) d](/filings/0001179929-26-000005.md) | [0.0](/filings/0001179929-26-000045.md) | [0.1](/filings/0001179929-26-000045.md) | [0.0](/filings/0001179929-26-000045.md) |
| Diluted EPS | $ per share | not reported | [5.17](/filings/0001179929-25-000070.md) | [5.17](/filings/0001179929-25-000119.md) | [5.65](/filings/0001179929-25-000128.md) | not reported | [5.45](/filings/0001179929-26-000023.md) | [4.75](/filings/0001179929-26-000039.md) | [1.51](/filings/0001179929-26-000045.md) | not reported | [0.27](/filings/0001179929-26-000023.md) | [1.19](/filings/0001179929-26-000039.md) | [0.73](/filings/0001179929-26-000045.md) |
| Basic EPS | $ per share | not reported | [5.21](/filings/0001179929-25-000070.md) | [5.18](/filings/0001179929-25-000119.md) | [5.67](/filings/0001179929-25-000128.md) | not reported | [5.47](/filings/0001179929-26-000023.md) | [4.75](/filings/0001179929-26-000039.md) | [1.51](/filings/0001179929-26-000045.md) | not reported | [0.27](/filings/0001179929-26-000023.md) | [1.19](/filings/0001179929-26-000039.md) | [0.74](/filings/0001179929-26-000045.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.8](/filings/0001179929-26-000005.md) | [4.5](/filings/0001179929-25-000070.md) | [4.4](/filings/0001179929-25-000119.md) | [4.7](/filings/0001179929-25-000128.md) | [4.7](/filings/0001179929-26-000005.md) | [4.9](/filings/0001179929-26-000023.md) | [4.5](/filings/0001179929-26-000039.md) | [4.2](/filings/0001179929-26-000045.md) | [4.2](/filings/0001179929-26-000045.md) | [5.3](/filings/0001179929-26-000023.md) | [5.0](/filings/0001179929-26-000039.md) | [4.5](/filings/0001179929-26-000045.md) |
| Current assets | $bn | [12.5](/filings/0001179929-25-000023.md) | [12.7](/filings/0001179929-24-000089.md) | [12.3](/filings/0001179929-24-000123.md) | [12.9](/filings/0001179929-24-000151.md) | [12.8](/filings/0001179929-26-000005.md) | [13.3](/filings/0001179929-25-000070.md) | [13.1](/filings/0001179929-25-000119.md) | [12.6](/filings/0001179929-25-000128.md) | [12.4](/filings/0001179929-26-000045.md) | [13.3](/filings/0001179929-26-000023.md) | [12.9](/filings/0001179929-26-000039.md) | [12.5](/filings/0001179929-26-000045.md) |
| Total assets | $bn | [14.9](/filings/0001179929-25-000023.md) | [15.5](/filings/0001179929-24-000089.md) | [15.2](/filings/0001179929-24-000123.md) | [15.8](/filings/0001179929-24-000151.md) | [15.6](/filings/0001179929-26-000005.md) | [16.4](/filings/0001179929-25-000070.md) | [16.2](/filings/0001179929-25-000119.md) | [15.7](/filings/0001179929-25-000128.md) | [15.6](/filings/0001179929-26-000045.md) | [16.4](/filings/0001179929-26-000023.md) | [16.0](/filings/0001179929-26-000039.md) | [15.7](/filings/0001179929-26-000045.md) |
| Current liabilities | $bn | [8.2](/filings/0001179929-25-000023.md) | [8.5](/filings/0001179929-24-000089.md) | [7.8](/filings/0001179929-24-000123.md) | [8.3](/filings/0001179929-24-000151.md) | [7.9](/filings/0001179929-26-000005.md) | [8.2](/filings/0001179929-25-000070.md) | [7.9](/filings/0001179929-25-000119.md) | [7.5](/filings/0001179929-25-000128.md) | [7.4](/filings/0001179929-26-000045.md) | [8.2](/filings/0001179929-26-000023.md) | [7.7](/filings/0001179929-26-000039.md) | [7.4](/filings/0001179929-26-000045.md) |
| Total liabilities | $bn | [10.7](/filings/0001179929-25-000023.md) | [11.0](/filings/0001179929-24-000089.md) | [10.3](/filings/0001179929-24-000123.md) | [11.0](/filings/0001179929-24-000151.md) | [11.1](/filings/0001179929-26-000005.md) | [12.1](/filings/0001179929-25-000070.md) | [11.6](/filings/0001179929-25-000119.md) | [11.5](/filings/0001179929-25-000128.md) | [11.5](/filings/0001179929-26-000045.md) | [12.3](/filings/0001179929-26-000023.md) | [11.8](/filings/0001179929-26-000039.md) | [11.5](/filings/0001179929-26-000045.md) |
| Long-term debt | $bn | [2.2](/filings/0001179929-25-000023.md) | [2.2](/filings/0001179929-24-000089.md) | [2.2](/filings/0001179929-24-000123.md) | [2.3](/filings/0001179929-24-000151.md) | [2.9](/filings/0001179929-26-000005.md) | [3.6](/filings/0001179929-25-000070.md) | [3.4](/filings/0001179929-25-000119.md) | [3.7](/filings/0001179929-25-000128.md) | [3.8](/filings/0001179929-26-000045.md) | [3.8](/filings/0001179929-26-000023.md) | [3.8](/filings/0001179929-26-000039.md) | [3.8](/filings/0001179929-26-000045.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.2](/filings/0001179929-26-000005.md) | [4.5](/filings/0001179929-25-000128.md) | [4.8](/filings/0001179929-25-000128.md) | [4.8](/filings/0001179929-25-000128.md) | [4.5](/filings/0001179929-26-000045.md) | [4.3](/filings/0001179929-26-000045.md) | [4.6](/filings/0001179929-26-000045.md) | [4.2](/filings/0001179929-26-000045.md) | [4.1](/filings/0001179929-26-000045.md) | [4.1](/filings/0001179929-26-000045.md) | [4.2](/filings/0001179929-26-000045.md) | [4.2](/filings/0001179929-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(690) d](/filings/0001179929-26-000005.md) | [214](/filings/0001179929-25-000070.md) | [(219) d](/filings/0001179929-25-000119.md) | [873 d](/filings/0001179929-25-000128.md) | [(224) d](/filings/0001179929-26-000005.md) | [190](/filings/0001179929-26-000023.md) | [(302) d](/filings/0001179929-26-000039.md) | [(125) d](/filings/0001179929-26-000045.md) | [(298) d](/filings/0001179929-26-000005.md) | [1,082](/filings/0001179929-26-000023.md) | [(294) d](/filings/0001179929-26-000039.md) | [(159) d](/filings/0001179929-26-000045.md) |
| Capital expenditure | $m | [(5.0) d](/filings/0001179929-26-000005.md) | [27.0](/filings/0001179929-25-000070.md) | [27.0 d](/filings/0001179929-25-000119.md) | [35.0 d](/filings/0001179929-25-000128.md) | [11.0 d](/filings/0001179929-26-000005.md) | [22.0](/filings/0001179929-26-000023.md) | [42.0 d](/filings/0001179929-26-000039.md) | [38.0 d](/filings/0001179929-26-000045.md) | [(1.0) d](/filings/0001179929-26-000005.md) | [27.0](/filings/0001179929-26-000023.md) | [30.0 d](/filings/0001179929-26-000039.md) | [37.0 d](/filings/0001179929-26-000045.md) |
| Share repurchases | $m | [0.0 d](/filings/0001179929-26-000005.md) | [0.0](/filings/0001179929-25-000070.md) | [0.0 d](/filings/0001179929-25-000119.md) | [500 d](/filings/0001179929-25-000128.md) | [500 d](/filings/0001179929-26-000005.md) | [500](/filings/0001179929-26-000023.md) | [0.0 d](/filings/0001179929-26-000039.md) | [500 d](/filings/0001179929-26-000045.md) | [0.0 d](/filings/0001179929-26-000005.md) | [0.0](/filings/0001179929-26-000023.md) | [0.0 d](/filings/0001179929-26-000039.md) | [0.0 d](/filings/0001179929-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [58.0](/filings/0001179929-24-000089.md) | [57.9](/filings/0001179929-24-000123.md) | [58.1](/filings/0001179929-24-000151.md) | [58.3](/filings/0001179929-25-000070.md) | [58.2](/filings/0001179929-25-000119.md) | [57.7](/filings/0001179929-25-000128.md) | [54.8](/filings/0001179929-26-000023.md) | [53.7](/filings/0001179929-26-000039.md) | [52.5](/filings/0001179929-26-000045.md) | [51.0](/filings/0001179929-26-000023.md) | [51.3](/filings/0001179929-26-000039.md) | [51.5](/filings/0001179929-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,200,000 at 2026-10-16, from the cover of the [10-Q filed 2026-10-22](/filings/0001179929-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.